US healthcare reform is advancing into unchartered territory with healthcare providers migrating from fee-based, volume-driven care to value-based, patient-centered care, ultimately positioning the patient in the center of their approach to care. Ambulatory surgery centers (ASC) in particular, are seeing new opportunities to improve financial performance, while advancing safety and quality of patient care. The rise in minimally invasive surgery is a driving factor for the ASC market, which puts medical devices such as orthopedic, neurosurgery, urology and ophthalmology products at the forefront. Reimbursement for ACS, however, is declining as they face competition from hospitals and outpatient centers. Medical device manufacturers must gain a better understanding of the current healthcare environment and how value based purchasing will ultimately affect product uptake, pricing and reimbursement.
- Discuss the impact of ASC healthcare and reimbursement trends in 2018
- Explain the Outpatient Prospective Payment System (OPPS) Final Rule 2018
- Outline CMS initiatives for “Meaningful Measures”
- Reveal the growing impact of patients as consumers
- Outline the changes in Alternative Payment Models
- Review how private payers are seeking Alternative Payment Models
Speaker:
Marilyn Denegre-Rumbin JD, MBA
Director, Payor-Reimbursement Strategy Strategy and Business Development
CARDINAL HEALTH
Contact:
Brooke Akins | Division Director, Life Science Programs
+1 (312) 224-1693
bakins@q1productions.com
